Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 24 | AVTE Aerovate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 18.9 | 12,500 | 236.25 k | 12,500 |
15 May 24 | VERA Vera Therapeutics | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 42.69 | 14,000 | 597.66 k | 14,000 |
25 Mar 24 | VERA Vera Therapeutics | Class A Common Stock | Sell | Dispose S | Yes | No | 40.5 | 340,000 | 13.77 mm | 2,793,987 |
22 Mar 24 | VERA Vera Therapeutics | Class A Common Stock | Sell | Dispose S | Yes | No | 40.51 | 413,450 | 16.75 mm | 3,133,987 |
21 Mar 24 | VERA Vera Therapeutics | Class A Common Stock | Sell | Dispose S | Yes | No | 46.18 | 13,718 | 633.50 k | 3,547,437 |
21 Mar 24 | VERA Vera Therapeutics | Class A Common Stock | Sell | Dispose S | Yes | No | 45.52 | 12,617 | 574.33 k | 3,561,155 |
21 Mar 24 | VERA Vera Therapeutics | Class A Common Stock | Sell | Dispose S | Yes | No | 44 | 21,918 | 964.39 k | 3,573,772 |
21 Mar 24 | VERA Vera Therapeutics | Class A Common Stock | Sell | Dispose S | Yes | No | 43 | 32,756 | 1.41 mm | 3,595,690 |
26 Feb 24 | RYZB RayzeBio | Common Stock | Sale back to company | Dispose D | Yes | No | 62.5 | 1,209,764 | 75.61 mm | 0 |
26 Feb 24 | RYZB RayzeBio | Common Stock | Sale back to company | Dispose D | Yes | No | 62.5 | 1,209,764 | 75.61 mm | 0 |